Company news

Sareum Holdings plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Sierra Oncology to Present at ASCO Annual Meeting

May 25, 2017

Sareum to Present at BioTrinity 2017

May 9, 2017

Director Shareholding

March 9, 2017

Half-year Results

February 20, 2017

Milestone Payment from Chk1 Licence Agreement

January 9, 2017

Result of General Meeting

December 22, 2016

Directors' Remuneration & General Meeting

December 6, 2016

Sareum to Present at AACR-NCI-EORTC Conference

November 29, 2016

Successful Outcome from TYK2 Feasibility Study

October 24, 2016

Japan and Singapore Patent Grants

October 17, 2016

Licence agreement for Chk1 Inhibitor CCT245737

September 27, 2016

China & HK Patent Grants for Sareum's Aurora+FLT3

August 3, 2016

Movement in share price

July 28, 2016

Clinical Trials CHK1 Inhibitor CCT245737 to Open

May 23, 2016

Change of Director

May 17, 2016

CHK1 Approved for Clinical Trials

April 5, 2016

Share price movement

March 10, 2016

Research & Co-Development Collaborations Update

February 24, 2016

Half-Yearly Results for December 2015

February 24, 2016

CHK1 Clinical Trial Application Submissions

February 1, 2016

CHK1 Clinical Trial Applications

December 15, 2015

US and European Patent Grants for Aurora+FLT3

September 15, 2015

CHK1 Research Update

July 23, 2015

Funding Award from Innovate UK

June 17, 2015

Sareum Launches New Website

May 21, 2015

Sareum to Present at BioTrinity 2015

May 12, 2015

Early Conclusion of Equity Swap Agreement

May 7, 2015

Research & Co-Development...

February 25, 2015

Half-yearly report

February 25, 2015

Further US Patent Grant for Kinase Inhibitors

January 20, 2015

Result of AGM

December 17, 2014

CHK1 Update

December 15, 2014

Chinese Patent Grant for...

December 4, 2014

Issue of Options

November 26, 2014

Notice of AGM

November 10, 2014

First Patent Grant for Sa...

November 10, 2014

Final Results

October 14, 2014

Promising Step in Psoriasis Drug Development

October 1, 2014

CHK1 Patent Update

September 22, 2014

Holding(s) in Company

September 9, 2014

Japanese Patent Grant for Kinase Inhibitors

July 2, 2014

Total Voting Rights

June 30, 2014

Preclinical Proof of Concept in TYK2 Programme

June 26, 2014

Issue of Equity

June 13, 2014

Research Update & Co-Deve...

February 26, 2014

Co-Development Agreement

December 2, 2013

Correction: Notice of AGM

November 13, 2013

Placing to raise £1.67 million

November 1, 2013

Sareum to Present at London Investor Show

October 25, 2013

Co-development Agreement to Advance CHK1 Programme

September 24, 2013

← Newer news releases · Older news releases →

Calls

The 5 newest of 13 calls. Every call is listed under its year.

Decks

The 5 newest of 8 decks. Every deck is listed under its year.